You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 17 No. 5, November 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

The Dynamics of a Lipidosis

Turnover of Sulfatide, Steroid Sulfate, and Polysaccharide Sulfate in Metachromatic Leukodystrophy

Hugo W. Moser, MD; Ann B. Moser; Guy M. McKhann, MD

Arch Neurol. 1967;17(5):494-511.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Metachromatic leukodystrophy (MLD) is the most common inborn error of metabolism affecting the white matter of human brain. In 1958, both Jatzkewitz1 and Austin2 demonstrated independently that the sulfatide concentration in the central nervous system (CNS) was increased in MLD, and a similar increase of sulfatide in peripheral nerve, kidney, liver, gallbladder, and urine has also been reported.3,4 Austin first pointed to an enzymatic defect in MLD by demonstrating a deficiency of arylsulfatase A.5,6 In vitro desulfation of sulfatide by a cerebroside sulfatase was first accomplished by Mehl and Jatzkewitz7 with a preparation of hog kidney. Subsequently, this enzyme also was isolated from normal human kidney and was found to be lacking in the kidney from a patient with MLD.8 Cerebroside sulfatase activity depends upon two components of relatively high molecular weight, one heat-labile, the other heat-stable.8 It appears that, in MLD, . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Department of Neurology, Harvard Medical School, Cambridge, Mass; the Joseph P. Kennedy, Jr. Memorial Laboratories and the Neurology Service at the Massachusetts General Hospital, Boston; and the Walter E. Fernald State School, Waltham, Mass. Dr. McKhann is a Lt. Joseph P. Kennedy, Jr., Senior Research Scholar and a John and Mary R. Markle Scholar in Academic Medicine. His present address is the Department of Pediatrics, Lt. Joseph P. Kennedy, Jr. Memorial Laboratories for Molecular Medicine, Stanford University School of Medicine, Palo Alto, Calif.


Footnotes

Submitted for publication May 29, 1967; accepted June 23.

Reprint requests to Department of Neurology, Massachusetts General Hospital, 1811 Fruit St, Boston 02114 (Dr. Moser).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.